Literature DB >> 2339504

The oscillatory potentials in response to stimuli of photopic intensities delivered in dark-adaptation: an explanation for the conditioning flash effect.

P Lachapelle1, J Benoit, L Blain, P Guité, M S Roy.   

Abstract

Previous studies reported that the oscillatory potentials (OPs) evoked to the first flash of a series were always smaller than those produced by the later flashes. This conditioning flash effect (CFE) was suggested to arise from rod inhibition of cone-mediated OPs. We investigated this CFE with the use of two stimulus intensities: 10 cd sec m-2 and 1 cd sec m-2. While the highest intensity did yield the previously reported CFE, the dimmest intensity did not. Our results further indicated that with the brightest stimulus, there is a significant increase in the interpeak interval of the OPs, while dimmest stimuli failed to reveal a similar marked increase. We also noted a significant correlation between the frequency domain of the OPs (as estimated with the interpeak interval) and the amplitude of the OPs (individual or collective: SOPs). Our results would also suggest that the observed CFE could result from a cone inhibition of rod-mediated OPs.

Entities:  

Mesh:

Year:  1990        PMID: 2339504     DOI: 10.1016/0042-6989(90)90062-p

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  10 in total

1.  Relationships between the electroretinogram a-wave, b-wave and oscillatory potentials and their application to clinical diagnosis.

Authors:  H Asi; I Perlman
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  The human suprathreshold photopic oscillatory potentials: method of analysis and clinical application.

Authors:  P Lachapelle
Journal:  Doc Ophthalmol       Date:  1994       Impact factor: 2.379

3.  Recording the oscillatory potentials of the electroretinogram with the DTL electrode.

Authors:  P Lachapelle; J Benoit; J M Little; B Lachapelle
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

4.  Longitudinal assessment of retinal structure and function reveals a rod-cone degeneration in a guinea pig model initially presented as night blind.

Authors:  Julie Racine; Sandrine Joly; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2011-06-08       Impact factor: 2.379

5.  Evidence supportive of a functional discrimination between photopic oscillatory potentials as revealed with cone and rod mediated retinopathies.

Authors:  P Lachapelle; S Rousseau; M McKerral; J Benoit; R C Polomeno; R K Koenekoop; J M Little
Journal:  Doc Ophthalmol       Date:  1998       Impact factor: 2.379

6.  Electrophysiological measures of dysfunction in early-stage diabetic retinopathy: No correlation between cone phototransduction and oscillatory potential abnormalities.

Authors:  J Jason McAnany; Karen Liu; Jason C Park
Journal:  Doc Ophthalmol       Date:  2019-09-11       Impact factor: 2.379

7.  Comparison of the second and third oscillatory potentials with oscillatory potential power in early diabetic retinopathy.

Authors:  K van der Torren; P Mulder
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

8.  Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse.

Authors:  M Cayouette; D Behn; M Sendtner; P Lachapelle; C Gravel
Journal:  J Neurosci       Date:  1998-11-15       Impact factor: 6.167

9.  Structural and functional maturation of the retina of the albino Hartley guinea pig.

Authors:  Julie Racine; Darren Behn; Pierre Lachapelle
Journal:  Doc Ophthalmol       Date:  2007-11-22       Impact factor: 2.379

10.  Oscillatory Potentials in Achromatopsia as a Tool for Understanding Cone Retinal Functions.

Authors:  Giulia Righetti; Melanie Kempf; Christoph Braun; Ronja Jung; Susanne Kohl; Bernd Wissinger; Eberhart Zrenner; Katarina Stingl; Krunoslav Stingl
Journal:  Int J Mol Sci       Date:  2021-11-24       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.